RBFOX1 and schizophrenia: To test this hypothesis, we applied a novel technical strategy that combines multi-label in situ hybridization and immunohistochemistry in postmortem human brain to quantify the levels of cytoplasmic Rbfox1 isoform and Vamp1 mRNA in the same PVIs in the PFC of individuals with schizophrenia.